Skip to content
Oncology Research Hub

Connecticut

Cancer clinical trials in Connecticut

238 cancer studies are recruiting participants at sites in 29 cities across Connecticut as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Connecticut city with a recruiting study

By research area: Breast Cancer (82), Lung Cancer (65), Lymphoma (40), Prostate Cancer (26), Pancreatic Cancer (16), Melanoma (9).

New Haven (183), Hartford (50), Trumbull (35), Stamford (34), Guilford (31), Derby (28), North Haven (28), Waterbury (28), Waterford (28), Fairfield (26), Torrington (26), Greenwich (24), Glastonbury (19), West Haven (13), Norwalk (12), Norwich (10), Meriden (7), New Britain (7), Orange (6), Danbury (5), Hamden (5), Bridgeport (4), Manchester (4), Avon (3), Farmington (2), Branford (1), Long Ridge (1), New Have (1), Willimantic (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Connecticut

Basic details from each study's public record (the 12 most recently updated of 238). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Recruiting in
    New Haven
    Registry record
    NCT06324357 · updated
  2. Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    EMD Serono Research & Development Institute, Inc.
    Recruiting in
    New Haven
    Registry record
    NCT07360314 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Connecticut on ClinicalTrials.gov.

Lung cancer: recently updated in Connecticut

  1. Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    New Haven · North Haven · Trumbull
    Registry record
    NCT06287775 · updated
  2. A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    New Haven
    Registry record
    NCT07513376 · updated
  3. A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BioNTech SE
    Recruiting in
    New Haven
    Registry record
    NCT07111520 · updated
  4. Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Derby · Fairfield · Greenwich · and 9 more U.S. locations
    Registry record
    NCT04267848 · updated
  5. Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers

    • Observational
    • All ages
    • All sexes
    Sponsor
    Lung Cancer Mutation Consortium
    Recruiting in
    Hartford
    Registry record
    NCT04712877 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Connecticut on ClinicalTrials.gov.

Prostate cancer: recently updated in Connecticut

  1. High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    VA Office of Research and Development
    Recruiting in
    West Haven
    Registry record
    NCT05011383 · updated
  2. Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    New Haven
    Registry record
    NCT06136624 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Connecticut on ClinicalTrials.gov.

Lymphoma: recently updated in Connecticut

  1. A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

    • Phase 2
    • Ages 1 to 30
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Hartford
    Registry record
    NCT04546399 · updated
  2. Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    New Haven
    Registry record
    NCT05272384 · updated
  3. A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

    • Phase 3
    • Ages 5 to 60
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Derby · Fairfield · Glastonbury · and 10 more U.S. locations
    Registry record
    NCT05675410 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Connecticut on ClinicalTrials.gov.

Ask about studies in Connecticut

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call